413 results on '"Liebowitz M"'
Search Results
2. Moderators and predictors of response to cognitive-behavioral therapy augmentation of pharmacotherapy in obsessive-compulsive disorder
3. Effects of fenfluramine on plasma homovanillic acid in healthy subjects
4. Evaluation of the Clinical Global Impression Scale among individuals with social anxiety disorder
5. The Liebowitz Social Anxiety Scale: a comparison of the psychometric properties of self-report and clinician-administered formats
6. An empirical approach to subtype identification in individuals with social phobia
7. Psychometric properties of the Liebowitz Social Anxiety Scale1
8. Disability and quality of life in pure and comorbid social phobia. Findings from a controlled study
9. Treatment of Atypical Depression: Phenelzine, Imipramine, and Placebo
10. Predicting birth weight in fetuses with gastroschisis
11. A Randomized, Controlled Trial of Cognitive-Behavioral Therapy for Augmenting Pharmacotherapy in Obsessive-Compulsive Disorder
12. Efficacy of venlafaxine XR and placebo in social anxiety disorder: Effects of gender and physical symptoms
13. Exposure and Response Prevention Therapy Reduce OCD Relapse More Than Medication Alone
14. P.3.064 Efficacy of safety of venlafaxine XR and paroxetine in the short-term treatment of SAD
15. Social Phobia or Social Anxiety Disorder: What's in a Name?
16. Discapacidad y calidad de vida en fobia social pura y comórbida. Resultados de un estudio controlado
17. Disability and quality of life in pure and comorbid social phobia – Findings from a controlled study
18. E045 Sibutramine induces weight loss but not BP increase in obese hypertensive patients taking beta-blockers
19. A 2-year study of sertraline in the treatment of obsessive-compulsive disorder
20. Issues in the design of trials for the evaluation of psychopharmacological treatments for social phobia
21. Issues in the design of trials for the evaluation of psychosocial treatments for social phobia
22. Treatment of obsessive—compulsive disorder with fluvoxamine
23. P-6-14 Long-term sertraline treatment of obsessive compulsive disorder: A 2 year study
24. Functional classification of anxiety-panic
25. Comparison of clomipramine, alprazolam and placebo in the treatment of obsessive—compulsive disorder
26. Pharmacotherapy of Social Phobia
27. EFFICACY OF FLUVOXAMINE IN OCD: A SECOND MULTICENTER STUDY
28. Myth of the pure obsessional type in obsessive--compulsive disorder.
29. Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders
30. Neuroendocrine predictors of response to intravenous clomipramine therapy for refractory obsessive–compulsive disorder <FNR></FNR><FN>Presented in part at the 2000 APA meeting May, Chicago, Illinois, Young Investigators Poster, and the 2001 ADAA Conference in Atlanta, Georgia </FN>
31. Social anxiety disorder: recent findings in the areas of epidemiology, etiology, and treatment.
32. Open trial of nefazodone among Hispanics with major depression: efficacy, tolerability, and adherence issues.
33. New DSM-IV diagnosis of acute stress disorder.
34. Relation of marital status to social phobia severity.
35. Managing generalized anxiety disorder.
36. Subsyndromal ("mixed") anxiety--depression in primary care.
37. Differential Diagnosis and Treatment of Panic Attacks and Phobic States.
38. Discriminating between generalized anxiety disorder and anxiety disorder not otherwise specified in a Hispanic population: Is it only a matter of worry?<FNR></FNR><FN>The opinions expressed in this article are those of the authors and do not necessarily represent the position of the American Psychiatric Association or its Task Force on DSM-IV. </FN>
39. Placebo-controlled trial of moclobemide in social phobia.
40. Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial.
41. Personality features of patients with primary affective disorder.
42. Subtypes of ataques de nervios: the influence of coexisting psychiatric diagnosis.
43. The mitral valve prolapse--panic disorder connection.
44. Cognitive-behavior therapy for panic disorder delivered by psychopharmacologically oriented clinicians.
45. Metabolism of (-) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit: a biochemical assessment.
46. Nutritional influences of pellagra on sebum composition.
47. Chronic Catheterization of Coronary Artery.
48. Symptom provocation alters behavioral ratings and brain electrical activity in obsessive-compulsive disorder: a preliminary study
49. Serotonergic function in social phobia: comparison to normal control and obsessive-compulsive disorder subjects
50. Effects of intravenous diazepam pretreatment on lactate-induced panic
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.